₹
1096.40
Oct 8
Business Description
Astec Lifesciences Ltd
ISIN : INE563J01010
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 1.34 | |||||
Debt-to-EBITDA | -9.72 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.7 | |||||
Beneish M-Score | -2.44 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.2 | |||||
3-Year FCF Growth Rate | -4.2 | |||||
3-Year Book Growth Rate | 6.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 25.94 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.21 | |||||
9-Day RSI | 24.27 | |||||
14-Day RSI | 30.75 | |||||
6-1 Month Momentum % | -4.91 | |||||
12-1 Month Momentum % | -12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 0.51 | |||||
Days Inventory | 283.55 | |||||
Days Sales Outstanding | 134.64 | |||||
Days Payable | 126.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -5.91 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.42 | |||||
Operating Margin % | -23.62 | |||||
Net Margin % | -20.4 | |||||
FCF Margin % | -32.56 | |||||
ROE % | -19.89 | |||||
ROA % | -8.22 | |||||
ROIC % | -7.39 | |||||
3-Year ROIIC % | -26.16 | |||||
ROC (Joel Greenblatt) % | -11.08 | |||||
ROCE % | -16.64 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 132.98 | |||||
Shiller PE Ratio | 69.45 | |||||
PS Ratio | 5.59 | |||||
PB Ratio | 5.82 | |||||
Price-to-Tangible-Book | 6.15 | |||||
Price-to-Operating-Cash-Flow | 210.36 | |||||
EV-to-EBIT | -30.39 | |||||
EV-to-EBITDA | -52.01 | |||||
EV-to-Revenue | 6.87 | |||||
EV-to-FCF | -21.7 | |||||
Price-to-Median-PS-Value | 1.57 | |||||
Earnings Yield (Greenblatt) % | -3.3 | |||||
FCF Yield % | -5.83 | |||||
Forward Rate of Return (Yacktman) % | 6.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Astec Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 3,847.047 | ||
EPS (TTM) (₹) | -40.01 | ||
Beta | 0.73 | ||
Volatility % | 43.88 | ||
14-Day RSI | 30.75 | ||
14-Day ATR (₹) | 45.778688 | ||
20-Day SMA (₹) | 1204.1225 | ||
12-1 Month Momentum % | -12 | ||
52-Week Range (₹) | 825.05 - 1474.4 | ||
Shares Outstanding (Mil) | 19.61 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Astec Lifesciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Astec Lifesciences Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Astec Lifesciences Ltd Frequently Asked Questions
What is Astec Lifesciences Ltd(NSE:ASTEC)'s stock price today?
When is next earnings date of Astec Lifesciences Ltd(NSE:ASTEC)?
Does Astec Lifesciences Ltd(NSE:ASTEC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |